You are here: Home » Medicine Notes , Pathology Notes » CYSTIC FIBROSIS
Typical Presentations
Persistent pulmonary infection, failure to thrive, pancreatic insufficiency, meconium ileus in newborns
Epidemiology
Most common lethal genetic disease in Caucasians
1 in 2500 Caucasians births; 1 in 17,000 African-American births
Genetics
Autosomal Recessive
Mutation in cystic fibrosis transmembrane regulator (CFTR) protein
CFTR protein = Chloride channel
Mutation associated with defective ion transport in epithelial cells
Causes thick, viscous secretions in lungs, pancreas, liver, intestine, and reproductive tract
Delta F508 is the most common mutation - single phenylalanine deletion at amino acid 508 on long arm of chromosome 7
Manifestions: Pulmonary Disease
Persistent, productive cough; Hyperinflation on CXR; Pulmonary function tests consistent with obstructive airway disease; Bronchiectasis; Digital clubbing
Colonization
Pseudomonas aeruginosa
Heavy, slime producing mucoid variant unique to CF patients
Once colonized, almost impossible to eradicate
Burkholderia cepacia complex
Associated with shortened survival and progressive disease acceleration
Staphylococcus aureus and haemophilus influenzae infections common during early childhood
Chest xray: Hyperinflation and bilateral infiltrates in CF patient Chest CT: Bronchiectasis in CF
Manifestations: Other Affected Organs
Gastrointestinal tract
Meconium ileus in newborns: pathognomonic
Meconium ileus equivalent in older children and adults: distal ileal obstruction
Sinuses
Chronic nasal congestion, Nasal polyps, Sinusitis
Pancreas
Pancreatic insufficency: Steatorrhea, Deficiency of fat soluble vitamins (A, D, E, and K), Failure to thrive
Chronic pancreatitis
Exocrine deficiency: Diabetes Mellitus
l Atrophy, fatty infiltration, and fibrosis of pancreatic exocrine glands
Reproductive tract
Male infertility: Defect in sperm transport, affecting more than 95%
Female infertility: Related to production of abnormally tenacious cervical mucus, affecting up to 20%
Biliary tree
Focal biliary cirrhosis or fatty liver infiltration
Cholelithiasis
Focal biliary Cirrhosis
Musculoskeletal
Low bone mineral density: Higher risk of fracture
Hypertrophic osteoarthropathy: Periosteal new bone formation
CF associated arthropathy: Short episodes of pain and swelling in the joints
Diagnosis
Sweat testing (Pilocarpine Iontophoresis) – gold standard
Molecular Diagnosis: Genotyping – 30 of 1250 most common mutations now screened
Nasal potential difference - after perfusion with amiloride and chloride-free solution
Treatment
Antibiotics: Tobramycin with an anti-pseudomonal penicillin or 3rd generation cephalosporin
Mucolytics: DNAse, N-acetylcysteine, Hypertonic saline
Bronchodilators: b2 – agonists, Anti-cholinergics, Anti-leukotrienes
Anti-inflammatory agents: Corticosteroids, Ibuprofen
Other: Physiotherapy, Airway clearance devices, Exercise, Supplemental oxygen, Lung transplantation
Nutrition: pancreatic enzymes, vitamin supplements, nocturnal feeds (G tubes, NG tubes)
VIII. Future Directions
Gene therapy: Under-study, in – vivo manipulation is promising
Gentamicin: Allows read-through of premature stop codons and allows synthesis of complete CFTR gene
Improved antibiotics: Defensins - cationic peptides that have antimicrobial properties
References:
1. Rowe, SM, Miller, S, Sorscher, EJ. Cystic fibrosis. N Engl J Med 2005; 352:1992.
2. Ratjen, F, Doring, G. Cystic fibrosis. Lancet 2003; 361:681
3. Gibson, RL, Burns, JL, Ramsey, BW. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am J Respir Crit Care Med 2003; 168:918.
4. DiSant'Agnese, PA, Hubbard, VS. The pancreas. In: Cystic Fibrosis, Taussig, LM (Ed), Thieme-Stratton, New York, 1984, p.230.
5. DiSant'Agnese, PA, Hubbard, VS. The gastrointestinal tract. In: Cystic Fibrosis, Taussig, LM (Ed), Thieme-Stratton, New York, 1984, p. 296.
6. Stern, RC. The diagnosis of cystic fibrosis. N Engl J Med 1997; 336:487.
Category: Medicine Notes , Pathology Notes
POST COMMENT
0 comments:
Post a Comment